Goodnites Wart Remover

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the removal of common warts and plantar warts.

There are no teratogenic or nonteratogenic effects mentioned in the available data.

Dosage and Administration

The affected area should be cleaned and softened with warm water before drying thoroughly. The wart remover is to be applied to each affected area using the provided disposable applicator. Treatment should be administered twice daily, once in the morning and once in the evening. This regimen should be followed consistently for optimal results.

Contraindications

Use of this product is contraindicated in the following situations:

Swallowing the product requires immediate medical attention or contact with a Poison Control Center (1-800-222-1222).

Contact with eyes should be avoided; if exposure occurs, rinse thoroughly with water for 15 minutes.

Inhalation of fumes is also contraindicated.

Warnings and Precautions

For external use only. It is imperative that healthcare professionals advise patients to avoid ingestion of the product. In the event of accidental swallowing, immediate medical assistance should be sought. Patients should be instructed to contact a Poison Control Center at 1-800-222-1222 without delay.

Healthcare providers should ensure that patients are aware of these critical safety measures to prevent potential adverse effects associated with improper use.

Side Effects

For external use only. Patients should be advised to avoid contact with eyes and mucous membranes. In the event of accidental contact, the affected area should be rinsed thoroughly with water. No specific adverse reactions have been reported in clinical trials or postmarketing experiences beyond this warning.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Goodnites Wart Remover (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric use has not been specifically addressed in the available data. There are no recommended age ranges, dosing differences, safety concerns, or special precautions for pediatric patients, including infants, children, and adolescents. Healthcare professionals should exercise caution when considering the use of this medication in the pediatric population due to the lack of specific information.

Geriatric Use

There is no specific information regarding the use of Goodnites Wart Remover (salicylic acid liquid) in geriatric patients. The prescribing information does not provide guidance on dosage adjustments, safety concerns, or special precautions for elderly patients. Therefore, healthcare providers should exercise caution and consider individual patient factors when administering this product to geriatric patients, as the absence of specific data necessitates careful monitoring and assessment of treatment outcomes in this population.

Pregnancy

The product has not been evaluated for safety in pregnancy, and its use during this period is not recommended due to potential risks to the fetus. There are no specific studies available regarding the effects of salicylic acid on pregnancy outcomes, which raises concerns about its safety profile in pregnant patients.

Given the lack of data, it is essential for pregnant women to consult a healthcare provider before using this product. No dosage modifications are specified for pregnant individuals, but caution is advised due to the unknowns surrounding fetal impacts.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication. It is advisable to monitor breastfed infants for any potential effects, although no specific information is available.

Renal Impairment

Renal impairment may necessitate dosage adjustments for patients with reduced kidney function. It is important to monitor renal function tests in these patients to ensure safety and efficacy. Additionally, a reduced dose should be considered for patients with decreased creatinine clearance to mitigate the risk of adverse effects.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, increased severity of known side effects, altered mental status, or any unusual physiological responses.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. Healthcare professionals should also consider contacting a poison control center for additional guidance on the management of overdose cases.

It is crucial to document any instances of suspected overdose and report them to the appropriate regulatory authorities to enhance the understanding of the medication's safety profile.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center at 1-800-222-1222 if the product is swallowed.

Patients should be informed to avoid contact with their eyes while using this product. In the event of accidental eye contact, they should rinse their eyes with water for at least 15 minutes and seek medical attention if irritation persists.

It is important to counsel patients on the risks associated with inhaling fumes from the product. They should be instructed to use the product in a well-ventilated area to minimize exposure.

Additionally, healthcare providers should remind patients to close the cap tightly after use and to store the product at room temperature, ensuring it is kept away from heat sources to maintain its efficacy and safety.

Storage and Handling

The product is supplied in a configuration that includes a tightly sealed cap. It is essential to store the product at room temperature, ensuring it is kept away from heat sources to maintain its integrity and efficacy.

Additional Clinical Information

The product is administered topically, with a recommended application of once in the morning and once in the evening on a daily basis. Clinicians should advise patients to avoid contact with the eyes; in the event of contact, patients should rinse their eyes with water for 15 minutes. Additionally, patients are cautioned against inhaling fumes and should ensure the cap is tightly closed, storing the product at room temperature and away from heat sources. If ingested, patients should seek medical assistance or contact a Poison Control Center immediately at 1-800-222-1222.

No further information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Goodnites Wart Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)